Skip NavigationSkip to Content
Return Return to Search Results

Novel high-throughput electrochemiluminescent assay for identification of human tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors and characterization of furamidine (NSC 305831) as an inhibitor of Tdp1

  1. Author:
    Antony, S.
    March, C.
    Stephen, A. G.
    Thibaut, L.
    Agama, K. K.
    Fisher, R. J.
    Pommier, Y.

  2. Author Address

    NCI, NIH, Canc Res Ctr, Mol Pharmacol Lab, Bethesda, MD 20892 USA. SAIC Frederick Inc, Protein Chem Lab, Adv Technol Program, Ft Detrick, MD 21702 USA.;Antony, S, NCI, NIH, Canc Res Ctr, Mol Pharmacol Lab, Bethesda, MD 20892 USA.;antonys@mail.nih.gov
    1. Year: 2007
  2. Journal: Nucleic Acids Research
    1. 35
    2. 13
    3. Pages: 4474-4484
  4. Type of Article: Article
  5. ISSN: 0305-1048
  1. Abstract:

    By enzymatically hydrolyzing the terminal phosphodiester bond at the 3'-ends of DNA breaks, tyrosyl-DNA phosphodiesterase (Tdp1) repairs topoisomerase-DNA covalent complexes and processes the DNA ends for DNA repair. To identify novel Tdp1 inhibitors, we developed a high-throughput assay that uses electrochemiluminescent (ECL) substrates. Subsequent to screening of 1981 compounds from the 'diversity set' of the NCl-Developmental Therapeutics Program, here we report that furamidine inhibits Tdp1 at low micromolar concentrations. Inhibition of Tdp1 by furamidine is effective both with single- and double-stranded substrates but is slightly stronger with the duplex DNA. Surface plasmon resonance studies show that furamidine binds both single-and double-stranded DNA, though more weakly with the single-stranded substrate DNA. Thus, the inhibition of Tdp1 activity could in part be due to the binding of furamidine to DNA. However, the inhibition of Tdp1 by furamidine is independent of the substrate DNA sequence. The kinetics of Tdp1 inhibition by furamidine was influenced by the drug to enzyme ratio and duration of the reaction. Comparison with related dications shows that furamidine inhibits Tdp1 more effectively than berenil, while pentamidine was inactive. Thus, furamidine represents the most potent Tdp1 inhibitor reported to date.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1093/nar/gkm463
  3. View record in Web of Science®
  4. WOS: 000249390600022

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel